Vol. 17 • Na. 1 • March 2015

In this issue:

• Observational study in an outpatient clinic specializing in treating opioid- dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine
  Metz V.E., Comer S.D., Pribasnig A., Wuerzl J., and Fischer G.
• Methadone deaths in Scotland
  Nikolaou V., and Luty J.
• Psychological needs of men under MMT- A mixed method study
  Jalali A., Hassanpuor-Dehkordi A., Mahvar T., Moradi M., and Dinmohammadi M.
• Prescription opioids (substitution medications and pain medications) in patients looking for Opioid Agonist Treatment in Northern and Southern Italy, using a 18-month survey methodology
  Maremmani I., Guareschi M., Deruvo G., Somaini L., Maremmani A.G.I., Green J., McBride K., and Dart R.C.
• Economic Evaluation of Suboxone® for substitution treatment of opioid drug dependence in Portugal
  Gouveia M., Sousa R., Costa J., and Borges M.
• Experts beliefs on suicide among illicit drug users
  Lovrecic M., Lovrecic B., and Dernovsek M.Z.
• Prospective pathways between heroin use and nonmedical use of prescription opioids: Trajectories among young Swiss men
  Baggio S., Iglesias K., Fournier N., Studer J., N'Goran A., Deline S., Mohler-Kuo M., and Gmel G.
• Consequences of cardiac toxicity in patients on low methadone doses during methadone maintenance treatment
  Mijatovic V., Samojlik I., Petkovic S., Uvelin A., Dickov A., Popov T., and Pejakovic J.
• Outcomes of buprenorphine-naloxone maintenance therapy: One-year follow up study from Turkey
  Mutlu E., and Bilici R.
• Subjective quality of life in drug addicted patients: A cross-treatment comparison
  Ambroziak A.

Vol. 17 • Na. 2-3 • June 2015

In this issue:

• Controversy or misunderstanding?
  Maremmani I.
• The Level of Readiness for HCV treatment among infected drug users at the centre for prevention and treatment of drug addicts in Celje, Slovenia
  Gabrovec B.
• Psychopathological symptoms in detoxified and non-detoxified heroin-dependent patients entering residential treatment
  Pani P.P., Maremmani A.G.I., Trogu E., Vigna-Taglianti F., Mathis F., Diecidue R., Kirchmayer U., Amato L., Davoli M., Ghibaudi J., Composeragna A., Saponaro A., Faggiano F., and Maremmani I.
• The extent of misuse and diversion of medication for opioid substitution treatment: a review and expert opinions
  Alho H., D'Agnone O., Krajci P., McKeganey N., Maremmani I., Reimer J., Roncero C., Somaini L., Wright N., and Littlewood R.
• Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights
  Brandt L., Fischberger S., Unger A., Jagsch R., Moser L., and Fischer G.
• Psychometric evaluation of the Slovenian translation of the Circumstances, Motivation and Readiness Scales
  Delić M., Kajdiž K., Melnick G., and Pregelj P.
• Psychosocially assisted pharmacological treatment of opioid dependence – treatment practice and political regime in Germany
  Deimel D., and Stover H.
• Is Agonist Opioid Treatment (AOT) best done by GPs or in a specialized setting?
  Haraldsen M.

Vol. 17 • Na. 4 • August 2015

In this issue:

• Towards the future of the treatment of heroin addiction. New challenges/issues to be addressed
  Maremmani I., and Maremmani A.G.I.
• Antagonist Opioid Medications in Mental Illness: State of Art and Future Perspectives
  Maremmani I., Rovai L., Maremmani A.G.I., Bacciardi S., Rugani F., Massimetti E., Gazzarrini D., Pallucchini A., and Janiri L.
• The prevalence of methamphetamine, MDMA and new drugs among opiate addicts on Agonist Opioid Treatment
  Gabrovec B.
• Suicide by narcotic poisoning in Slovenia, according to gender, during the period 2004-2007
  Lovrecic M., Lovrecic B., Selb Semerl J., and Maremmani I.

Vol. 17 • Na. 5 • October 2015

In this issue:

• Gender Differences in Opioid Maintenance Treatment
  Schoofs N., Wiers C., Bald L.K., Bermpohl F., and Gutwinski S.
• Optimising Service Provision for Prescribed Opioid Analgesic Dependence
  Marr E., and Hill D.
• Overdose Risk Perceptions and Experience of Overdose among Heroin Users in Cork, Ireland. Preliminary Results from a Pilot Overdose Prevention Study
  Horan A.J., Deasy C., Henry K., O Brien D., and Van Hout M.C.
• Opioid Agonist Maintenance Treatment: A Short Guide for Beginners
  Trogu E.
• Misuse and Diversion of Opioid Agonist Opioid Treatment Medicines: Assessment of the Scale of the Problem and Review of the Changing Environment for Care in the Nordic Countries
  Alho H., Jansen J., Krajci P., Littlewood R., Rúnarsdóttir V., and Nyberg F.
• An Inventory for Assessing the Behavioural Covariates of Craving in Heroin Substance Use Disorder. Development, Theoretical De-Scription, Reliability, Exploratory Factor Analysis and Preliminary Construct Validity
  Maremmani A.G.I., Rovai L., Bacciardi S., Massimetti E., Gazzarrini D., Rugani F., Pallucchini A., Piz L., and Maremmani I.

Vol. 17 • Na. 6 • December 2015

In this issue:

• The Finger and the Moon. Alarming reactions to the opioid overdose alarm
  Pacini M., and Maremmani I.
• Towards a specific psychopathology of heroin addiction. Comparison between Heroin Use Disorder and Major Depression patients.
  Maremmani A.G.I., Cerniglia L., Cimino S., Bacciardi S., Rovai L., Rugani F., Massimetti E., Gazzarrini D., Pallucchini A., Pani P.P., Akiskal H.H., and Maremmani I.
• Case series of heroin induced non-cardiac pulmonary edema
  Arslan E.D., Büyükcam F., Avcı S., Genç S., Demir Ö.F., Usul E., Birgi E., Aydın M., and Özkan S.
• Is there any relationship between drug users' bereavement and substance consumption?
  Masferrer L., Garre-Olmo J., and Caparros B.
• Effects of treatment diversification on neonatal abstinence syndrome:1999-2002 vs. 2009-2012
  Unger A., Brandt L., Fischberger S., Moser L., Fischer G., and Jagsch R.
• Correlation between methadone dosage, cortisol plasma level and depression in methadone maintained patients
  Ignjatova L., Spasovska Trajanovska A., and Bonevski D.
• Life events (loss and traumatic) and emotional responses to them in acute catastrophe survivors and long-lasting heroin use disorder patients never exposed to catastrophic events
  Dell'Osso L., Massimetti E., Rugani F., Carmassi C., Fareed A., Stratta P., Rossi A., Massimetti G., and Maremmani I.